Skip to content

Effect of Chaihuang Qingyi Huoxue Granule on Intestinal Microecological Disturbance in Patients with Acute Pancreatitis

Mechanism of Active Ingredients and Druggability Optimization of Chaihuang Qingyi Huoxue Granule in Treating Severe Acute Pancreatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001430
Enrollment
Unknown
Registered
2025-07-16
Start date
2025-07-31
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute pancreatitis

Interventions

Sponsors

The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Meet the diagnostic criteria for MAP or MSAP outlined in the "Guidelines for the Diagnosis and Treatment of Acute Pancreatitis in China (2021)". Meet the diagnostic criteria for the pattern as per the "Consensus of Experts on Traditional Chinese Medicine for Acute Pancreatitis (2024)". Are aged between 18 and 65 years (inclusive) regardless of gender. Are admitted to the hospital within 72 hours after the onset of acute pancreatitis. Are willing to participate in this study and provide signed informed consent either personally or through a legal representative. They must also agree to use effective contraceptive methods during the trial period.

Exclusion criteria

Exclusion criteria: 1. Patients with SAP. 2. Patients who have used traditional Chinese medicine (TCM) preparations after disease onset. 3. Patients who have used antibiotic or probiotic medications or foods in the past month. 4. Patients participating in or having participated in other drug clinical trials within the past 4 weeks. 5. Patients with known severe cardiovascular respiratory renal hepatic or hematological diseases as well as those with severe immunodeficiency malignant tumors epilepsy etc. 6. Patients with clinical conditions affecting TCM and enteral nutrition administration via the gastrointestinal tract such as significant intestinal ischemia or obstruction severe abdominal distension or abdominal compartment syndrome active gastrointestinal bleeding or high gastrointestinal fistulas without satisfactory enteral nutrition tube placement. 7. Pregnant or breastfeeding women.

Design outcomes

Primary

MeasureTime frame
intestinal flora abundance;Gastrointestinal Recovery Time;

Secondary

MeasureTime frame
Fecal metabolomics;Traditional Chinese Medicine (TCM) syndromes score.;

Countries

China

Contacts

Public ContactLi Zhi

The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University

lizhi_swmu@126.com+86 189 8025 1819

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026